smart city tech

City of Houston partners with digital waste, recycling solutions company

Mayor Sylvester Turner says this new smart city technology partner will help digitize and optimize waste operations. Photo via rubicon.com

The City of Houston announced that it has entered into a three-year partnership with Kentucky-based Rubicon with the goal of improving its waste, recycling, and heavy-duty municipal fleet operations.

According to a statement, the city has installed the company's RUBICONSmartCity platform on the Solid Waste Management Department’s 391 vehicles, and has trained the workforce on using the SaaS software.

“Partnering with Rubicon will help our great city optimize its solid waste operations and make it possible for us to digitize our entire waste and recycling management system,” Mayor Sylvester Turner said in a statement. “The City of Houston is committed to providing the highest level of service to its residents and this partnership will allow us to provide better services, save taxpayer dollars, and deliver a better quality of life for Houstonians.”

RUBICONSmartCity is a cloud-based suite that will allow the department's workforce to track key metrics about pickup, including issues at the curb and recycling contamination, as well as information about its fleet of vehicles. The platform includes a mobile app, an onboard data collection device, and a web-based portal.

The city envisions that information collected by RUBICONSmartCity will enhance reporting tools used by 311 and give the department a better understanding of what's happening in the field.

“The City’s Department of Solid Waste can use this information to advise and educate residents around service scheduling, best practices for waste and recycling management, and reduce costly return trips,” Solid Waste Management Department Director Mark Wilfalk said in a statement. “These insights, alongside route optimization and digitization efforts, are set to deliver an optimal operation to the City of Houston.”

RUBICONSmartCity is used in more than 70 cities across the U.S., including San Antonio. The product was the focus of a 2021 Amazon documentary entitled "The Road to Zero Waste," which focused on Rubicon's work in Santa Fe, New Mexico.

“Our partnership with the City of Houston is off to a fantastic start, as we were able to install our products and train the entire Solid Waste Department’s workforce in only 73 days, an incredibly fast turn for such an undertaking,” Michael Allegretti, Chief Strategy Officer at Rubicon, said in a statement. "This partnership comes at a critically important time, as Houston and other cities across the nation look to maintain, and ultimately expand, service levels.”

In August 2021, the City of Houston also launched HTX Collects, a mobile app aimed at helping residents keep track of weekly services, updates, and waste collection days. At that time, the city estimated that it collected curbside service for over 395,000 residential homes within the city limits.

Trending News

Building Houston

 
 

InformAI has three AI-based products geared at improving health care. Photo via Getty Images

In Houston, we’re lucky to have top-tier doctors in the Texas Medical Center, ready to treat us with the newest technology. But what about our family members who have to rely on rural hospitals? Thanks to one Houston company, doctors in smaller community hospitals may soon have new tools at their disposal that could improve outcomes for patients around the world.

Since InnovationMap last caught up with Jim Havelka, CEO of InformAI, two years ago, that hope has come far closer to a reality. InformAI is a VC-backed digital health company. Part of JLABS @ TMC innovation facilities, the company uses artificial intelligence to develop both diagnostic tools and clinical outcome predictors. And two of the company’s products will undergo FDA regulatory testing this year.

SinusAI, which helps to detect sinus-related diseases in CT scans, received its CE Mark — the European equivalent of FDA approval — last year and is being sold across the Atlantic today, says Havelka. He adds that in the United States alone, there are roughly 700,000 sinus surgeries that the product is positioned to support.

Another product, RadOnc-AI, is designed to help doctors prescribe radiation dose plans for head and neck cancers.

“Ideally the perfect plan would be to provide radiation to the tumor and nothing around it,” says Havelka. “We’ve built a product, RadOnc-AI, which autogenerates the dose treatment plan based on medical images of that patient.”

It can be an hours-long process for doctors to figure out the path and dose of radiation themselves, but the new product “can build that initial pass in about five minutes,” Havelka says.

That in itself is an exciting development, but because this technology was developed using the expertise of some of the world’s top oncologists, “the first pass plan is in line with what [patients would] get at tier-one institutions,” explains Havelka. This creates “tremendous equity” among patients who can afford to travel to major facilities and those that can’t.

To that end, RadOnc-AI was recently awarded a $1.55 million grant from the Cancer Prevention and Research Institute of Texas, or CPRIT, a state agency that funds cancer research. The Radiological Society of North America announced late last year that InformAI was named an Aunt Minnie Best of Radiology Finalist.

“It’s quite prestigious for our company,” says Havelka. Other recent laurels include InformAI being named one of the 10 most promising companies by the Texas Life Science Forum in November.

And InformAI is only gaining steam. A third product is earlier in its stage of development. TransplantAI will optimize donor organ and patient recipient matches.

“A lot of organs are harvested and discarded,” Havelka says.

His AI product has been trained on a million donor transplants to help determine who is the best recipient for an organ. It even takes urgency into account, based on a patient’s expected mortality within 90 days. The product is currently a fully functional prototype and will soon move through its initial regulatory clearances.

The company — currently backed by three VC funds, including DEFTA Partners, Delight Ventures, and Joyance Partners — is planning to do another seed round in Q2 of 2023.

“We’ve been able to get recognized for digital health products that can be taken to market globally,” says Havelka.

But what he says he’s most excited about is the social impact of his products. With more money raised, InformAI will be able to speed up development of additional products, including expanding the cancers that the company will be targeting. And with that, more and more patients will one day be treated with the highest level of care.

Trending News